# US 2016/0250167 A1 · Volatile Organic Compound Formulations Having Antimicrobial Activity

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0250167 A1
- Document ID: US20160250167A1
- Status: Published application
- Kind: A1
- Application number: 14/322,757
- Filed: 2014-07-02
- Published: 2016-09-01
- Earliest claimed: 2013-07-02
- Assignees: Cineole Corp., LLC
- Applicants: Cineole Corp., LLC
- Inventors: Gary A. Strobel; Brian Blatt
- Web page: https://patentgrep.com/patent/US20160250167A1

## CPC

- A61K 31/19: Carboxylic acids, e.g. valproic acid (salicylic acid A61K31/60)
- A01N 37/02: Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
- A01N 37/12: containing the group [IMAGE cpc-sch-A01N-0932.gif], wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
- A61K 31/22: of acyclic acids, e.g. pravastatin
- A61K 36/062: Ascomycota
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The present invention includes novel chemical formulations having antimicrobial activity and their methods of use thereof. In some embodiments, the formulation further comprises at least one fungus.

## Claims

### Claim 1

A chemical formulation comprising propanoic acid, isobutyric acid, at least one ester, and at least one carrier, wherein the chemical formulation has antibacterial activity when applied to human or animal waste.

### Claim 2 (depends on 1)

The formulation of claim 1, wherein the at least one ester is isoamyl butyrate.

### Claim 3 (depends on 1)

The formulation of claim 1, wherein the at least one carrier is a silica based carrier.

### Claim 4 (depends on 3)

The formulation of claim 3, wherein the at least one carrier is selected from the group consisting of bentonite, zeolite and perlite.

### Claim 5 (depends on 2)

The formulation of claim 2, wherein the ratio of propanoic acid:isobutryic acid:isoamyl butyrate is about 3.5:3.5:2 v/v/v.

### Claim 6 (depends on 2)

The formulation of claim 2, wherein the ratio of propanoic acid, isobutryic acid and isoamyl butyrate is about 7 parts of the two acids and 2 parts of isoamyl butyrate.

### Claim 7

A chemical formulation consisting essentially of propanoic acid, isobutryic acid, isoamyl butyrate and a carrier.

### Claim 8 (depends on 7)

The chemical formulation of claim 7, wherein the carrier is selected from the group consisting of bentonite, zeolite and perlite.

### Claim 9 (depends on 7)

The chemical formulation of claim 7, wherein the chemical formulation has antibacterial activity when applied to human or animal waste.

### Claim 10

A chemical formulation, comprising:
propanoic acid;
isobutryic acid;
at least one ester;
at least one carrier; and
at least one fungus.

### Claim 11 (depends on 10)

The formulation of claim 10, wherein the at least one ester is isoamyl butyrate.

### Claim 12 (depends on 10)

The formulation of claim 10, wherein the at least one carrier is a silica based carrier.

### Claim 13 (depends on 12)

The formulation of claim 12, wherein the at least one carrier is selected from the group consisting of bentonite, zeolite and perlite.

### Claim 14 (depends on 11)

The formulation of claim 11, wherein the ratio of propanoic acid:isobutryic acid:isoamyl butyrate is about 3.5:3.5:2 v/v/v.

### Claim 15 (depends on 11)

The formulation of claim 11, wherein the ratio of propanoic acid, isobutryic acid and isoamyl butyrate is about 7 parts of the two acids and 2 parts of isoamyl butyrate.

### Claim 16 (depends on 10)

The formulation of claim 10, wherein the at least one fungus is an endophyte.

### Claim 17 (depends on 16)

The formulation of claim 16, wherein the endophyte is of the genus Fusarium.

### Claim 18 (depends on 17)

The formulation of claim 17, wherein the endophyte is F. subglutinans.

### Claim 19

A chemical formulation comprising propanoic acid and at least one 6-12 carbon (acid) component ester, wherein the chemical formulation has a ratio of propanoic acid:ester component of about 7:2 v/v.

### Claim 20 (depends on 19)

The formulation of claim 19, wherein the at least one ester is isoamyl hexanoates.

### Claim 21 (depends on 19)

The formulation of claim 19, further comprising at least one nutritional supplement and at least one salt.

### Claim 22 (depends on 21)

The formulation of claim 21, wherein the formulation comprises glucose, whey protein, potassium chloride, magnesium sulfate, and sodium chloride.

### Claim 23 (depends on 21)

The formulation of claim 21, wherein the formulation comprises glucose, glycine, potassium chloride, sodium chloride, and magnesium acetate.

### Claim 24 (depends on 21)

The formulation of claim 21, wherein the formulation comprises glucose, glycine, potassium chloride, sodium chloride, magnesium acetate, and monopotassium phosphate.

### Claim 25 (depends on 19)

The formulation of claim 19, further comprising at least one pharmaceutically acceptable carrier.

### Claim 26 (depends on 25)

The formulation of claim 25, wherein the carrier is cremophor.

### Claim 27 (depends on 20)

The formulation of claim 20, wherein the formulation consists essentially of propanoic acid and isoamyl hexanoates at a ratio of propanoic acid:isoamyl hexanoates of about 7:2 v/v.

### Claim 28 (depends on 19)

The formulation of claim 19, further comprising at least one carrier.

### Claim 29 (depends on 28)

The formulation of claim 28, wherein the at least one carrier is a silica based carrier.

### Claim 30 (depends on 29)

The formulation of claim 29, wherein the at least one carrier is selected from the group consisting of bentonite, zeolite and perlite.

### Claim 31

A chemical formulation consisting essentially of propanoic acid, isoamyl hexanoates and a carrier.

### Claim 32

A chemical formulation comprising propanoic acid and a single carbon (acid) component ester, wherein the chemical formulation has a ratio of propanoic acid:ester component of about 7:2 v/v.

### Claim 33 (depends on 32)

The formulation of claim 32, wherein the at least one ester is isoamyl formate.

### Claim 34 (depends on 33)

The formulation of claim 33, wherein the formulation consists essentially of propanoic acid and isoamyl formate at a ratio of propanoic acid:isoamyl formate of about 7:2 v/v.

### Claim 35 (depends on 32)

The formulation of claim 32, further comprising at least one carrier.

### Claim 36 (depends on 35)

The formulation of claim 35, wherein the at least one carrier is a silica based carrier.

### Claim 37 (depends on 36)

The formulation of claim 36, wherein the at least one carrier is selected from the group consisting of bentonite, zeolite and perlite.

### Claim 38

A chemical formulation consisting essentially of propanoic acid, isoamyl formate and a carrier.

### Claim 39

A chemical formulation, comprising:
propanoic acid;
isoamyl formate; and
at least one fungus.

### Claim 40 (depends on 39)

The formulation of claim 39, wherein the ratio of propanoic acid:isoamyl formate is about 7:2 v/v.

### Claim 41 (depends on 39)

The formulation of claim 39, wherein the at least one fungus is an endophyte.

### Claim 42 (depends on 41)

The formulation of claim 41, wherein the endophyte is of the genus Fusarium.

### Claim 43 (depends on 42)

The formulation of claim 42, wherein the endophyte is F. subglutinans.

### Claim 44

A method of treating human or animal waste, comprising contacting human or animal waste with a composition comprising propanoic acid, isobutryic acid and at least one ester, wherein the composition kills or reduces bacteria growth on the human or animal waste.

### Claim 45

A method of treating human or animal waste, comprising contacting human or animal waste with a composition comprising propanoic acid, isobutryic acid, at least one ester and at least one fungus, wherein the propanoic acid, isobutryic acid and at least one ester kills or reduces bacteria growth on the human or animal waste, and the at least one fungus increases the rate of decomposition of the human or animal waste.

### Claim 46

A method of eliminating or reducing microbial growth at a treatment site, comprising contacting the treatment site with a composition comprising propanoic acid and at least one ester at a ratio of propanoic acid:ester of about 7:2, wherein the ester is isoamyl formate or isoamyl hexanoates and the composition kills or reduces bacteria growth on the human or animal waste.

### Claim 47

A method of treating human or animal waste, comprising contacting human or animal waste with a composition comprising propanoic acid, isoamyl formate at a ratio of propanoic acid:isoamyl formate of about 7:2, and at least one fungus, wherein the propanoic acid and isoamyl formate mixture kills or reduces microbial growth on the human or animal waste, and the at least one fungus increases the rate of decomposition of the human or animal waste.

### Claim 48

A method of treating an animal having a disease or disorder associated with a microbial infection, comprising administering to the animal an effective amount of a composition comprising at least one organic acid.

### Claim 49 (depends on 48)

The method of claim 48, wherein the composition consists essentially of an organic acid.

### Claim 50 (depends on 48)

The method of claim 48, wherein the composition consists of an organic acid.

### Claim 51 (depends on 48)

The method of claim 48, wherein the at least one organic acid is propanoic acid.

### Claim 52 (depends on 48)

The method of claim 48, wherein the at least one organic acid is isobutyric acid.

### Claim 53 (depends on 48)

The method of claim 48, wherein the animal is a human.

### Claim 54 (depends on 53)

The method of claim 53, wherein the disease or disorder is a diarrheal disease.

### Claim 55 (depends on 48)

The method of claim 48, wherein the animal is bovine, porcine, or ovine.

### Claim 56 (depends on 55)

The method of claim 55, where the disease or disorder is selected from the group consisting of a diarrheal disease and an intramammary infection.

### Claim 57 (depends on 56)

The method of claim 56, wherein the diarrheal disease is scours.

### Claim 58 (depends on 56)

The method of claim 56, wherein the intramammary infection is subclinical mastitis or clinical mastitis.

### Claim 59 (depends on 48)

The method of claim 48, wherein the composition further comprises at least one ester.

### Claim 60 (depends on 59)

The method of claim 59, wherein the at least one ester is isoamyl hexanoates.

### Claim 61 (depends on 59)

The method of claim 59, wherein the composition further comprises at least one nutritional supplement and at least one salt.

### Claim 62 (depends on 61)

The method of claim 61, wherein the composition comprises glucose, whey protein, potassium chloride, magnesium sulfate, and sodium chloride.

### Claim 63 (depends on 61)

The method of claim 61, wherein the composition comprises glucose, glycine, potassium chloride, sodium chloride, and magnesium acetate.

### Claim 64 (depends on 61)

The method of claim 61, wherein the composition comprises glucose, glycine, potassium chloride, sodium chloride, magnesium acetate, and monopotassium phosphate.

### Claim 65 (depends on 48)

The method of claim 48, wherein the composition further comprises at least one pharmaceutically acceptable carrier.

### Claim 66 (depends on 65)

The method of claim 65, wherein the carrier is cremophor.

### Claim 67 (depends on 59)

The method of claim 59, wherein the composition comprises propanoic acid and isoamyl hexanoates at a ratio of propanoic acid:isoamyl hexanoates of about 7:2 v/v.

### Claim 68 (depends on 1)

The formulation of claim 1, wherein the at least one ester is isoamyl hexanoates.

### Claim 69 (depends on 68)

The formulation of claim 68, wherein the ratio of propanoic acid:isobutryic acid:isoamyl hexanoates is about 3.5:3.5:2 v/v/v.

### Claim 70 (depends on 68)

The formulation of claim 68, wherein the ratio of propanoic acid, isobutryic acid and isoamyl hexanoates is about 7 parts of the two acids and 2 parts of isoamyl butyrate.

### Claim 71

A chemical formulation consisting essentially of propanoic acid, isobutryic acid, isoamyl hexanoates and a carrier.

### Claim 72 (depends on 71)

The chemical formulation of claim 71, wherein the carrier is selected from the group consisting of bentonite, zeolite and perlite.

### Claim 73 (depends on 71)

The chemical formulation of claim 71, wherein the chemical formulation has antibacterial activity when applied to human or animal waste.

### Claim 74 (depends on 10)

The formulation of claim 10, wherein the at least one ester is isoamyl hexanoates.

### Claim 75 (depends on 74)

The formulation of claim 74, wherein the ratio of propanoic acid:isobutryic acid:isoamyl hexanoates is about 3.5:3.5:2 v/v/v.

### Claim 76 (depends on 74)

The formulation of claim 74, wherein the ratio of propanoic acid, isobutryic acid and isoamyl hexanoates is about 7 parts of the two acids and 2 parts of isoamyl hexanoates.

### Claim 77

A chemical formulation having antimicrobial activity comprising propanoic acid, isobutyric acid, and at least one ester.

### Claim 78 (depends on 77)

The formulation of claim 77, wherein the at least one ester is isoamyl hexanoates.

### Claim 79 (depends on 77)

The formulation of claim 77, further comprising at least one carrier selected from the group consisting of bentonite, zeolite and perlite.

### Claim 80 (depends on 78)

The formulation of claim 78, wherein the ratio of propanoic acid:isobutryic acid:isoamyl hexanoates is about 3.5:3.5:2 v/v/v.

### Claim 81 (depends on 78)

The formulation of claim 78, wherein the ratio of propanoic acid, isobutryic acid and isoamyl hexanoates is about 7 parts of the two acids and 2 parts of isoamyl butyrate.

### Claim 82

A chemical formulation consisting essentially of propanoic acid, isobutryic acid, isoamyl hexanoates and a carrier selected from the group consisting of bentonite, zeolite and perlite.

### Claim 83 (depends on 77)

The formulation of claim 77, further comprising at least one endophyte.

### Claim 84 (depends on 83)

The formulation of claim 83, wherein the endophyte is of the genus Fusarium.

### Claim 85

A chemical formulation comprising propanoic acid and at least one 6-12 carbon (acid) component ester, wherein the chemical formulation has a ratio of propanoic acid:ester component of about 7:2 v/v.

### Claim 86 (depends on 85)

The formulation of claim 85, wherein the at least one ester is isoamyl hexanoates.

### Claim 87 (depends on 85)

The formulation of claim 85, further comprising at least one nutritional supplement and at least one salt.

### Claim 88 (depends on 87)

The formulation of claim 87, wherein the formulation comprises glucose, whey protein, potassium chloride, magnesium sulfate, and sodium chloride.

### Claim 89 (depends on 87)

The formulation of claim 87, wherein the formulation comprises glucose, glycine, potassium chloride, sodium chloride, and magnesium acetate.

### Claim 90 (depends on 87)

The formulation of claim 87, wherein the formulation comprises glucose, glycine, potassium chloride, sodium chloride, magnesium acetate, and monopotassium phosphate.

### Claim 91 (depends on 85)

The formulation of claim 85, further comprising at least one carrier.

### Claim 92 (depends on 86)

The formulation of claim 86, wherein the formulation consists essentially of propanoic acid and isoamyl hexanoates at a ratio of propanoic acid:isoamyl hexanoates of about 7:2 v/v.

### Claim 93 (depends on 85)

The formulation of claim 85, further comprising at least one endophyte.

### Claim 94 (depends on 93)

The formulation of claim 93, wherein the endophyte is of the genus Fusarium.

### Claim 95

A method of treating an animal having a disease or disorder associated with a microbial infection, comprising administering to the animal an effective amount of a composition comprising at least one organic acid and at least one ester.

### Claim 96 (depends on 95)

The method of claim 95, wherein the composition comprises propanoic acid and at least one 6-12 carbon (acid) component ester, wherein the chemical formulation has a ratio of propanoic acid:ester component of about 7:2 v/v.
